 | • レポートコード：20QY06-03649 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ペルツズマブのグローバル市場について種類別（人由来、動物由来）、用途別（病院、医療センター）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ペルツズマブ市場の概要 ・世界の主要地域別ペルツズマブ市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のペルツズマブ市場規模2015-2026：種類別（人由来、動物由来） ・世界のペルツズマブ市場規模2015-2026：用途別（病院、医療センター） ・ペルツズマブの北米市場規模2015-2020 ・ペルツズマブのヨーロッパ市場規模2015-2020 ・ペルツズマブの中国市場規模2015-2020 ・ペルツズマブの日本市場規模2015-2020 ・ペルツズマブの東南アジア市場規模2015-2020 ・ペルツズマブのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Novartis AG、Pfizer、Abnova Corporation、InvivoGen、Celltrion、Biocon Limited、Bio-Techne） ・ペルツズマブの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ペルツズマブの市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Pertuzumab Market
The global Pertuzumab market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Pertuzumab Scope and Market Size
The global Pertuzumab market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pertuzumab market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pertuzumab market is segmented into
Human Source
Animal Source
Segment by Application, the Pertuzumab market is segmented into
Hospital
Medical Center
The Pertuzumab market is analysed and market size information is provided by regions (countries). Segment by Application, the Pertuzumab market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pertuzumab Market Share Analysis
Pertuzumab market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pertuzumab business, the date to enter into the Pertuzumab market, Pertuzumab product introduction, recent developments, etc.
The major vendors covered:
Novartis AG
Pfizer
Abnova Corporation
InvivoGen
Celltrion
Biocon Limited
Bio-Techne
…
Table of Contents
1 Pertuzumab Market Overview
1.1 Pertuzumab Product Scope
1.2 Pertuzumab Segment by Type
1.2.1 Global Pertuzumab Sales by Type (2020-2026)
1.2.2 Human Source
1.2.3 Animal Source
1.3 Pertuzumab Segment by Application
1.3.1 Global Pertuzumab Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Medical Center
1.4 Pertuzumab Market Estimates and Forecasts (2015-2026)
1.4.1 Global Pertuzumab Sales Growth Rate (2015-2026)
1.4.2 Global Pertuzumab Revenue and Growth Rate (2015-2026)
1.4.3 Global Pertuzumab Price Trends (2015-2026)
2 Pertuzumab Estimate and Forecast by Region
2.1 Global Pertuzumab Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Pertuzumab Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Pertuzumab Sales Market Share by Region (2015-2020)
2.2.2 Global Pertuzumab Revenue Market Share by Region (2015-2020)
2.3 Global Pertuzumab Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Pertuzumab Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Pertuzumab Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Pertuzumab Estimates and Projections (2015-2026)
2.4.2 Europe Pertuzumab Estimates and Projections (2015-2026)
2.4.3 China Pertuzumab Estimates and Projections (2015-2026)
2.4.4 Japan Pertuzumab Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Pertuzumab Estimates and Projections (2015-2026)
2.4.6 India Pertuzumab Estimates and Projections (2015-2026)
3 Global Pertuzumab Competition Landscape by Players
3.1 Global Top Pertuzumab Players by Sales (2015-2020)
3.2 Global Top Pertuzumab Players by Revenue (2015-2020)
3.3 Global Pertuzumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pertuzumab as of 2019)
3.4 Global Pertuzumab Average Price by Company (2015-2020)
3.5 Manufacturers Pertuzumab Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Pertuzumab Players (Opinion Leaders)
4 Global Pertuzumab Market Size by Type
4.1 Global Pertuzumab Historic Market Review by Type (2015-2020)
4.1.1 Global Pertuzumab Sales Market Share by Type (2015-2020)
4.1.2 Global Pertuzumab Revenue Market Share by Type (2015-2020)
4.1.3 Global Pertuzumab Price by Type (2014-2020)
4.2 Global Pertuzumab Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Pertuzumab Sales Forecast by Type (2021-2026)
4.2.2 Global Pertuzumab Revenue Forecast by Type (2021-2026)
4.2.3 Global Pertuzumab Price Forecast by Type (2021-2026)
5 Global Pertuzumab Market Size by Application
5.1 Global Pertuzumab Historic Market Review by Application (2015-2020)
5.1.1 Global Pertuzumab Sales Market Share by Application (2015-2020)
5.1.2 Global Pertuzumab Revenue Market Share by Application (2015-2020)
5.1.3 Global Pertuzumab Price by Application (2015-2020)
5.2 Global Pertuzumab Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Pertuzumab Sales Forecast by Application (2021-2026)
5.2.2 Global Pertuzumab Revenue Forecast by Application (2021-2026)
5.2.3 Global Pertuzumab Price Forecast by Application (2021-2026)
3 North America Pertuzumab Market Facts & Figures
3.2 North America Pertuzumab Sales Market Share by Company (2015-2020)
3.3 North America Pertuzumab Sales Market Share by Type (2015-2020)
3.4 North America Pertuzumab Sales Market Share by Application (2015-2020)
4 Europe Pertuzumab Market Facts & Figures
4.2 Europe Pertuzumab Sales Market Share by Company (2015-2020)
4.3 Europe Pertuzumab Sales Market Share by Type (2015-2020)
4.4 Europe Pertuzumab Sales Market Share by Application (2015-2020)
5 China Pertuzumab Market Facts & Figures
5.2 China Pertuzumab Sales Market Share by Company (2015-2020)
5.3 China Pertuzumab Sales Market Share by Type (2015-2020)
5.4 China Pertuzumab Sales Market Share by Application (2015-2020)
6 Japan Pertuzumab Market Facts & Figures
6.2 Japan Pertuzumab Sales Market Share by Company (2015-2020)
6.3 Japan Pertuzumab Sales Market Share by Type (2015-2020)
6.4 Japan Pertuzumab Sales Market Share by Application (2015-2020)
7 Southeast Asia Pertuzumab Market Facts & Figures
7.2 Southeast Asia Pertuzumab Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Pertuzumab Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Pertuzumab Sales Market Share by Application (2015-2020)
8 India Pertuzumab Market Facts & Figures
8.2 India Pertuzumab Sales Market Share by Company (2015-2020)
8.3 India Pertuzumab Sales Market Share by Type (2015-2020)
8.4 India Pertuzumab Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Pertuzumab Business
12.1 Novartis AG
12.1.1 Novartis AG Pertuzumab Corporation Information
12.1.2 Novartis AG Pertuzumab Business Overview and Total Revenue
12.1.3 Novartis AG Pertuzumab Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis AG Pertuzumab Products Offered
12.1.5 Novartis AG Recent Development
12.2 Pfizer
12.2.1 Pfizer Pertuzumab Corporation Information
12.2.2 Pfizer Pertuzumab Business Overview and Total Revenue
12.2.3 Pfizer Pertuzumab Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Pertuzumab Products Offered
12.2.5 Pfizer Recent Development
12.3 Abnova Corporation
12.3.1 Abnova Corporation Pertuzumab Corporation Information
12.3.2 Abnova Corporation Pertuzumab Business Overview and Total Revenue
12.3.3 Abnova Corporation Pertuzumab Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Abnova Corporation Pertuzumab Products Offered
12.3.5 Abnova Corporation Recent Development
12.4 InvivoGen
12.4.1 InvivoGen Pertuzumab Corporation Information
12.4.2 InvivoGen Pertuzumab Business Overview and Total Revenue
12.4.3 InvivoGen Pertuzumab Sales, Revenue and Gross Margin (2015-2020)
12.4.4 InvivoGen Pertuzumab Products Offered
12.4.5 InvivoGen Recent Development
12.5 Celltrion
12.5.1 Celltrion Pertuzumab Corporation Information
12.5.2 Celltrion Pertuzumab Business Overview and Total Revenue
12.5.3 Celltrion Pertuzumab Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Celltrion Pertuzumab Products Offered
12.5.5 Celltrion Recent Development
12.6 Biocon Limited
12.6.1 Biocon Limited Pertuzumab Corporation Information
12.6.2 Biocon Limited Pertuzumab Business Overview and Total Revenue
12.6.3 Biocon Limited Pertuzumab Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Biocon Limited Pertuzumab Products Offered
12.6.5 Biocon Limited Recent Development
12.7 Bio-Techne
12.7.1 Bio-Techne Pertuzumab Corporation Information
12.7.2 Bio-Techne Pertuzumab Business Overview and Total Revenue
12.7.3 Bio-Techne Pertuzumab Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Bio-Techne Pertuzumab Products Offered
12.7.5 Bio-Techne Recent Development
…
13 Pertuzumab Manufacturing Cost Analysis
13.1 Pertuzumab Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pertuzumab
13.4 Pertuzumab Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pertuzumab Distributors List
14.3 Pertuzumab Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Pertuzumab Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Pertuzumab Sales (K MT) Comparison by Application (2020-2026)
Table 3. Global Market Pertuzumab Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Pertuzumab Sales (K MT) by Region (2015-2020)
Table 5. Global Pertuzumab Sales Market Share by Region (2015-2020)
Table 6. Global Pertuzumab Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Pertuzumab Revenue Share by Region (2015-2020)
Table 8. Global Pertuzumab Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Pertuzumab Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Pertuzumab Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Pertuzumab Revenue Share Forecast by Region (2021-2026)
Table 12. Global Pertuzumab (K MT) of Key Companies (2015-2020)
Table 13. Global Pertuzumab Sales Share by Company (2015-2020)
Table 14. Global Pertuzumab Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Pertuzumab Revenue Share by Company (2015-2020)
Table 16. Global Pertuzumab by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pertuzumab as of 2019)
Table 17. Global Pertuzumab Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Pertuzumab Manufacturing Sites and Area Served
Table 19. Manufacturers Pertuzumab Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Pertuzumab Players
Table 22. Global Pertuzumab Sales (K MT) by Type (2015-2020)
Table 23. Global Pertuzumab Sales Share by Type (2015-2020)
Table 24. Global Pertuzumab Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Pertuzumab Price (K MT) by Type (2015-2020)
Table 26. Global Pertuzumab Sales Share by Type (2021-2026)
Table 27. Global Pertuzumab Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Pertuzumab Revenue Share by Type (2021-2026)
Table 29. Global Pertuzumab Price (K MT) by Type (2021-2026)
Table 30. Global Pertuzumab Sales (K MT) by Application (2015-2020)
Table 31. Global Pertuzumab Sales Share by Application (2015-2020)
Table 32. Global Pertuzumab Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Pertuzumab Price (K MT) by Application (2015-2020)
Table 34. Global Pertuzumab Sales (K MT) by Application (2021-2026)
Table 35. Global Pertuzumab Sales Share by Application (2021-2026)
Table 36. Global Pertuzumab Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Pertuzumab Revenue Share by Application (2021-2026)
Table 38. Global Pertuzumab Price (K MT) by Application (2021-2026)
Table 39. United States Pertuzumab Sales (K MT) by Company (2015-2020)
Table 40. United States Pertuzumab Sales Market Share by Company (2015-2020)
Table 41. United States Pertuzumab Sales (K MT) by Type (2015-2020)
Table 42. United States Pertuzumab Sales Market Share by Type (2015-2020)
Table 43. United States Pertuzumab Sales (K MT) by Application (2015-2020)
Table 44. United States Pertuzumab Sales Market Share by Application (2015-2020)
Table 45. Europe Pertuzumab Sales (K MT) by Company (2015-2020)
Table 46. Europe Pertuzumab Sales Market Share by Company (2015-2020)
Table 47. Europe Pertuzumab Sales (K MT) by Type (2015-2020)
Table 48. Europe Pertuzumab Sales Market Share by Type (2015-2020)
Table 49. Europe Pertuzumab Sales (K MT) by Application (2015-2020)
Table 50. Europe Pertuzumab Sales Market Share by Type (2015-2020)
Table 51. China Pertuzumab Sales (K MT) by Company (2015-2020)
Table 52. China Pertuzumab Sales Market Share by Company (2015-2020)
Table 53. China Pertuzumab Sales (K MT) by Type (2015-2020)
Table 54. China Pertuzumab Sales Market Share by Type (2015-2020)
Table 55. China Pertuzumab Sales (K MT) by Application (2015-2020)
Table 56. China Pertuzumab Sales Market Share by Application (2015-2020)
Table 57. Japan Pertuzumab Sales (K MT) by Company (2015-2020)
Table 58. Japan Pertuzumab Sales Market Share by Company (2015-2020)
Table 59. Japan Pertuzumab Sales (K MT) by Type (2015-2020)
Table 60. Japan Pertuzumab Sales Market Share by Type (2015-2020)
Table 61. Japan Pertuzumab Sales (K MT) by Application (2015-2020)
Table 62. Japan Pertuzumab Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Pertuzumab Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Pertuzumab Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Pertuzumab Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Pertuzumab Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Pertuzumab Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Pertuzumab Sales Market Share by Application (2015-2020)
Table 69. India Pertuzumab Sales (K MT) by Company (2015-2020)
Table 70. India Pertuzumab Sales Market Share by Company (2015-2020)
Table 71. India Pertuzumab Sales (K MT) by Type (2015-2020)
Table 72. India Pertuzumab Sales Market Share by Type (2015-2020)
Table 73. India Pertuzumab Sales (K MT) by Application (2015-2020)
Table 74. India Pertuzumab Sales Market Share by Application (2015-2020)
Table 75. Novartis AG Corporation Information
Table 76. Novartis AG Description and Business Overview
Table 77. Novartis AG Pertuzumab Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Novartis AG Pertuzumab Product
Table 79. Novartis AG Recent Development
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Pertuzumab Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Pfizer Pertuzumab Product
Table 84. Pfizer Recent Development
Table 85. Abnova Corporation Corporation Information
Table 86. Abnova Corporation Description and Business Overview
Table 87. Abnova Corporation Pertuzumab Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Abnova Corporation Pertuzumab Product
Table 89. Abnova Corporation Recent Development
Table 90. InvivoGen Corporation Information
Table 91. InvivoGen Description and Business Overview
Table 92. InvivoGen Pertuzumab Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. InvivoGen Pertuzumab Product
Table 94. InvivoGen Recent Development
Table 95. Celltrion Corporation Information
Table 96. Celltrion Description and Business Overview
Table 97. Celltrion Pertuzumab Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Celltrion Pertuzumab Product
Table 99. Celltrion Recent Development
Table 100. Biocon Limited Corporation Information
Table 101. Biocon Limited Description and Business Overview
Table 102. Biocon Limited Pertuzumab Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Biocon Limited Pertuzumab Product
Table 104. Biocon Limited Recent Development
Table 105. Bio-Techne Corporation Information
Table 106. Bio-Techne Description and Business Overview
Table 107. Bio-Techne Pertuzumab Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Bio-Techne Pertuzumab Product
Table 109. Bio-Techne Recent Development
Table 110. Production Base and Market Concentration Rate of Raw Material
Table 111. Key Suppliers of Raw Materials
Table 112. Pertuzumab Distributors List
Table 113. Pertuzumab Customers List
Table 114. Market Key Trends
Table 115. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 116. Key Challenges
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Pertuzumab Product Picture
Figure 2. Global Pertuzumab Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Pertuzumab Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Medical Center Examples
Figure 8. Global Pertuzumab Sales (K MT) Growth Rate (2015-2026)
Figure 9. Global Pertuzumab Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Pertuzumab Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Pertuzumab Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Pertuzumab Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Pertuzumab Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Pertuzumab Sales (K MT) Growth Rate (2015-2026)
Figure 15. Europe Pertuzumab Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Pertuzumab Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Pertuzumab Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Pertuzumab Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Pertuzumab Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Pertuzumab Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Pertuzumab Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Pertuzumab Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Pertuzumab Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Pertuzumab Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Pertuzumab Players Market Share by Revenue in Pertuzumab 2015 & 2019
Figure 26. Pertuzumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Pertuzumab Revenue Share by Type (2015-2020)
Figure 28. Global Pertuzumab Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Pertuzumab Revenue Share by Application (2015-2020)
Figure 30. Global Pertuzumab Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Pertuzumab Sales Market Share by Type in 2019
Figure 32. United States Pertuzumab Sales Market Share by Type in 2019
Figure 33. Europe Pertuzumab Sales Market Share by Company in 2019
Figure 34. Europe Pertuzumab Sales Market Share by Type in 2019
Figure 35. Europe Pertuzumab Sales Market Share by Application in 2019
Figure 36. China Pertuzumab Sales Market Share by Company in 2019
Figure 37. China Pertuzumab Sales Market Share by Type in 2019
Figure 38. China Pertuzumab Sales Market Share by Application in 2019
Figure 39. Japan Pertuzumab Sales Market Share by Company in 2019
Figure 40. Japan Pertuzumab Sales Market Share by Type in 2019
Figure 41. Japan Pertuzumab Sales Market Share by Application in 2019
Figure 42. Southeast Asia Pertuzumab Sales Market Share by Company in 2019
Figure 43. Southeast Asia Pertuzumab Sales Market Share by Type in 2019
Figure 44. Southeast Asia Pertuzumab Sales Market Share by Application in 2019
Figure 45. India Pertuzumab Sales Market Share by Company in 2019
Figure 46. India Pertuzumab Sales Market Share by Type in 2019
Figure 47. India Pertuzumab Sales Market Share by Application in 2019
Figure 48. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Abnova Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. InvivoGen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Celltrion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Biocon Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Bio-Techne Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Key Raw Materials Price Trend
Figure 56. Manufacturing Cost Structure of Pertuzumab
Figure 57. Manufacturing Process Analysis of Pertuzumab
Figure 58. Pertuzumab Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Porter's Five Forces Analysis
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
ペルツズマブの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Pertuzumab market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pertuzumab market report provides …- HER2抗体の世界市場レポート2020 Market Analysis and Insights: Global HER2 Antibody Market The global HER2 Antibody market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global HER2 Antibody Scope and Market Size The global HER2 Antibody market is se…
- HER2抗体の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global HER2 Antibody market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The HER2 Antibody market report pro…
- ヒトフィブリノーゲンの世界市場レポート2020 Fibrinogen is a protein in the blood plasma that is essential for the coagulation of blood and is converted to fibrin by the action of thrombin in the presence of ionized calcium. Human fibrinogen is a protein which is important for blood clotting (coagulation). The industry is concentration, the ke…
- 人乳オリゴ糖（HMO）の世界市場レポート2020 Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-ad…